ArticleMalaria journal2026
Guillain-Barré syndrome following Plasmodium falciparum malaria in a child: a case report.
Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGuillain-Barré syndrome (GBS) is an acute immune‑mediated polyradiculoneuropathy and remains a leading cause of acquired neuromuscular paralysis. In children, it typically follows infection, but association with malaria is rare. CASE PRESENTATION: We report a four‑year‑old Lebanese girl living in Nigeria, who developed progressive weakness, dysphagia, inspiratory stridor, and gait ataxia 2 weeks after treatment for Plasmodium falciparum malaria. Neurological examination revealed lower‑extremity weakness with areflexia, bulbar involvement causing stridor, unilateral facial weakness, and gait ataxia (Hughes score 4). Cerebrospinal fluid analysis showed albumin‑cytologic dissociation, and nerve conduction studies demonstrated acute inflammatory demyelinating polyradiculoneuropathy. Given the rapid progression and severity, therapeutic plasma exchange (PE) was administered (five exchanges over 10 days) along with supportive care. Strength improved steadily, and at 1 month she was able to walk and run independently (Hughes score 0).
conclusionsThis case expands the limited pediatric literature on malaria-associated GBS and highlights the importance of recognizing evolving bulbar and neurological symptoms after Plasmodium falciparum infection. Early supportive care and immunotherapy may contribute to favorable neurological recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.